Keri Ramsey, BSN, helps lead Origin’s Genomic Insights platform, dedicated to empowering doctors, caregivers, and organizations with specialized knowledge and resources to bridge the gap between world-leading genomic science and practical healthcare solutions. This ensures health systems can navigate the complex and evolving landscape of genomic medicine and deliver cutting-edge care.
She is also the Clinical Co-Director of the Center for Rare Childhood Disorders at the Translational Genomics Research Institute (TGen), where the goal is to use the latest advances in genetic sequencing to identify or provide insights into the causes of unexplained rare childhood disorders.
Keri began working at TGen in 2003 as Lead Technologist and Center Coordinator for the NINDS/NIMH Microarray Consortium. The Consortium supported gene expression profiling of the nervous system through microarray technologies, providing reagents, services, and training to the neuroscience community on a fee-for-service basis.
Keri contributes to several research studies. The largest uses next-generation sequencing to diagnose rare childhood disorders. Another study aims to identify genetic modifiers affecting Tuberous Sclerosis (TSC) patients and their parents. She is also the lead coordinator for a pharmaceutical study focused on improving the quality of life for girls and women with Rett syndrome, screening patients for enrollment, obtaining consent from families, collecting tissue specimens, and updating families on study progress while assisting in returning research results.
She earned her nursing degree from Arizona State University, spending four years as a Certified Critical Care Nurse in the Neuro Intensive Care Unit at Banner Good Samaritan (now Banner University Medical Center Phoenix).